Abstract 4376: Preclinical characterization of SGR-4174, a potent and selective SOS1 inhibitor for the treatment of pan KRAS mutant cancers in combination with KRAS pathway inhibitors
Year: 2025
Type: conference-abstract
Source: Cancer Research
Authors: Hui Wang, Felicia Gray, Christian Atsriku, Adam M. Levinson, Andrew Placzek, Evelyne M. Houang, Abba E. Leffler, Anatoly Ruvinsky, Leah Frye, Jeremy Greenwood, Mats Svensson, Jeff Bell, Zhijian Liu, Roman Shimanovich, Matt Liu, Shaoxian Sun
Institution: Schrodinger (United States)
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4409627291